A new demography and aging population, chronic diseases, increased competition, as well as budget constraints demand innovative therapies, pharmaceuticals, medical devices and services. It is crucial for managers in pharmaceutical and medical organizations to gain an in-depth understanding and knowledge of value creation.

The "MBA - Specialization Biotech, Pharma & MedTech Management" builds on a solid theoretical framework complemented by case studies, excursions and discussions with peers. Graduates of the program will be part of a network of successful innovators and entrepreneurs in the field and will be prepared to take over demanding managerial positions in biopharmaceutical and medical device companies in a competitive international environment.

The four specialization modules can also be booked as Certificate Program "Biotech, Pharma & MedTech Management". The modules completed can be credited in terms of content and financially for "MBA - Specialization Biotech, Pharma & MedTech Management".

Akkreditierung

 

 

ACCREDITED: The program is internationally accredited by ACBSP. Danube Business School is member of the PRME initiative of the United Nations.

Target group

Executives and entrepreneurs in biotechnology, medical technology, pharmaceutical companies as well as health care organizations, with education in the field of natural sciences, especially medicine, pharmacy, medical technology as well as economics, legal studies or IT.

Course options
Master of Business Administration
Learning format
Duration
4 semesters, part time
possible variants
ETCS-Points
90
Costs
EUR 23.900,--
further conditions
Start
continuously possible
Language
English
Curriculum
Study location
University for Continuing Education Krems
Dr.-Karl-Dorrek-Straße 30
3500 Krems
Austria
Organizer

Scientific Direction

Contact

Questions about the study course?

Please feel free to contact us directly.

Studying in Krems

Follow us

Back to top